The Only Company in the Pharmaceutical and Biotech Industry
Three-Year Grace Period from Non-Compliant Disclosure Designation

Hugel announced on the 6th that it was the only company in the pharmaceutical and biotech industry to be selected as a '2025 KOSDAQ Market Disclosure Excellence Corporation'.


The Korea Exchange annually evaluates KOSDAQ-listed companies based on disclosure accuracy, timeliness, appropriateness, and the proactiveness of IR activities. Based on these criteria, it selects the following: ▲ Outstanding Comprehensive Evaluation Corporations ▲ Outstanding IR Activity Corporations ▲ Outstanding Long-term Faithful Disclosure Corporations. This year, only 15 companies out of the total 1,916 KOSDAQ-listed firms received the honor.

Kyungwook Min, Head of KOSDAQ Market Division at Korea Exchange (from left), Duhyun Jang, CEO of Hugel, and Jaewon Heo, Executive Director of Financial Planning at Hugel, are posing together for a commemorative photo at the '2025 KOSDAQ Market Disclosure Excellence Corporation' awards ceremony held at the Korea Exchange Seoul headquarters on the 5th. Hugel

Kyungwook Min, Head of KOSDAQ Market Division at Korea Exchange (from left), Duhyun Jang, CEO of Hugel, and Jaewon Heo, Executive Director of Financial Planning at Hugel, are posing together for a commemorative photo at the '2025 KOSDAQ Market Disclosure Excellence Corporation' awards ceremony held at the Korea Exchange Seoul headquarters on the 5th. Hugel

View original image

Recognized as an Outstanding Comprehensive Evaluation Corporation, Hugel has earned eligibility for a three-year grace period from being designated as a non-compliant disclosure corporation. The company will also receive preferential benefits, such as exemption from mandatory training for disclosure officers and staff. Hugel explained that this recognition was the result of its accurate and prompt disclosure of key management information—including performance, major business developments, and corporate briefing activities—which has helped enhance investor understanding and contributed to reducing information asymmetry in the securities market.



Doohyun Jang, CEO of Hugel, stated, "We will continue to strengthen shareholder trust and strive to foster a fair securities market environment through compliant disclosure practices."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing